Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Blocking advanced glycation end products (AGEs) and protein cross-linking

Anti-Glycation & AGEs Cross-link Inhibition · Metabolic sensing, autophagy and longevity

Activates transketolase to divert triose phosphates, or binds highly reactive dicarbonyl compounds such as methylglyoxal directly, to block irreversible glycation and stiffening of collagen and the microvascular basement membrane.

Why it matters: A core biochemical shield against vessel wall stiffening, retinopathy and collagen aging, blocking the microvascular degeneration caused by high blood sugar.

Molecular targets: Transketolase, Methylglyoxal, RAGE receptor, AGE cross-link breakage

Supplements acting on this mechanism (ranked by strength and evidence)

Benfotiamine (fat-soluble vitamin B1)

★★★☆☆Mechanism evidence: grade A

After conversion to thiamine diphosphate, benfotiamine can support transketolase activity, shifting more glycolytic intermediates into the pentose phosphate pathway. Transketolase activity rose in a randomized human trial, but advanced glycation end products (AGEs) did not fall consistently.

L-carnosine

★★★☆☆Mechanism evidence: grade C

The imidazole ring and amino group in the carnosine molecule can bind reactive carbonyl compounds, which lets it trap some glycation intermediates. A human trial showed that it increased urinary carnosine–acrolein adducts, but this marker does not show that glycation crosslinking in tissue is inhibited.

Open in the interactive app ›